scholarly article | Q13442814 |
P356 | DOI | 10.1097/01.WNR.0000223394.66951.48 |
P698 | PubMed publication ID | 16791082 |
P2093 | author name string | Raj N Kalaria | |
Takeshi Tabira | |||
Wee-Chuang Low | |||
Keikichi Takahashi | |||
Yo Santa | |||
P433 | issue | 10 | |
P304 | page(s) | 945-949 | |
P577 | publication date | 2006-07-01 | |
P1433 | published in | NeuroReport | Q15710007 |
P1476 | title | CADASIL-causing mutations do not alter Notch3 receptor processing and activation | |
P478 | volume | 17 |
Q30861866 | CADASIL and CARASIL. |
Q36459076 | CADASIL mutations and shRNA silencing of NOTCH3 affect actin organization in cultured vascular smooth muscle cells |
Q33470786 | Cadasil |
Q37105606 | Clusterin/Apolipoprotein J immunoreactivity is associated with white matter damage in cerebral small vessel diseases |
Q30487788 | Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain |
Q38433566 | Genetic factors in cerebral small vessel disease and their impact on stroke and dementia |
Q35008186 | Hypomorphic Notch 3 alleles link Notch signaling to ischemic cerebral small-vessel disease |
Q28387429 | Mutations of NOTCH3 in childhood pulmonary arterial hypertension |
Q37294787 | NOTCH1 mutations in individuals with left ventricular outflow tract malformations reduce ligand-induced signaling |
Q39648981 | Potent inhibitors of amyloid β fibrillization, 4,5-dianilinophthalimide and staurosporine aglycone, enhance degradation of preformed aggregates of mutant Notch3 |
Q38089232 | Review: cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy |
Q34571315 | Sequestration of latent TGF-β binding protein 1 into CADASIL-related Notch3-ECD deposits |
Q48256255 | The archetypal R90C CADASIL-NOTCH3 mutation retains NOTCH3 function in vivo |
Q39970746 | Therapeutic NOTCH3 cysteine correction in CADASIL using exon skipping: in vitro proof of concept. |
Search more.